Mucosal inflammation in a genetic model of spontaneous type I diabetes mellitus

被引:19
作者
Hardin, JA
Donegan, L
Woodman, RC
Trevenen, C
Gall, DG
机构
[1] Univ Calgary, Fac Med, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Immunol Res Grp, Calgary, AB T2N 4N1, Canada
[3] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada
关键词
diabetes; inflammation; myeloperoxidase; jejunum;
D O I
10.1139/Y02-138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The BioBreeding (BB) rat provides a model of spontaneous type I diabetes mellitus that closely resembles the human disease. Diabetes-prone BB rats demonstrate increased intestinal permeability prior to the development of insulinitis. Studies suggest that alterations in intestinal permeability can lead to increased intestinal inflammatory activity. Diabetes-prone (BBdp) and diabetes-resistant (BBdr) BB rats were examined at 45 days and at >70 days of age following the development of clinical disease (BBd). In separate experiments, tissue was assayed for myeloperoxidase (MPO) or fixed for histological assessment and immunohistochemistry. Blood was obtained for leukocyte MPO measurements and morphological assessment of circulating leukocytes. MPO activity was significantly elevated in the distal small intestine of 45-day-old BBdp rats. In contrast, at >70 days of age, MPO activity was significantly increased throughout the small intestine of BBd and non-diabetic BBdp rats. Subsequently, all measurements were performed in >70-day-old rats. An increase in inflammatory infiltrate was noted in the distal small intestine of BBd rats by light microscopy. Infiltrating cells were identified as bands (a maturing cell type of the neutrophil lineage) and mature neutrophils. The findings suggest diabetes susceptibility is associated with an increase in intestinal inflammatory activity.
引用
收藏
页码:1064 / 1070
页数:7
相关论文
共 31 条
  • [1] [Anonymous], 1992, INFLAMMATION BASIC P
  • [2] Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats
    Bellmann, K
    Kolb, H
    Rastegar, S
    Jee, P
    Scott, FW
    [J]. DIABETOLOGIA, 1998, 41 (07) : 844 - 847
  • [3] BJARNASON I, 1987, SCAND J RHEUMATOL, P55
  • [4] Breslin NP, 2001, AM J GASTROENTEROL, V96, P2934
  • [5] THE EFFECTS OF STREPTOZOTOCIN DIABETES ON SODIUM-GLUCOSE TRANSPORTER (SGLT1) EXPRESSION AND FUNCTION IN RAT JEJUNAL AND ILEAL VILLUS-ATTACHED ENTEROCYTES
    DEBNAM, ES
    SMITH, MW
    SHARP, PA
    SRAI, SKS
    TURVEY, A
    KEABLE, SJ
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1995, 430 (02): : 151 - 159
  • [6] ALTERED GLUCOSE CARRIER EXPRESSION - MECHANISM OF INTESTINAL ADAPTATION DURING STREPTOZOCIN-INDUCED DIABETES IN RATS
    FEDORAK, RN
    CHEESEMAN, CI
    THOMSON, ABR
    PORTER, VM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04): : G585 - G591
  • [7] INDUCTION OF INTESTINAL GLUCOSE CARRIERS IN STREPTOZOCIN-TREATED CHRONICALLY DIABETIC RATS
    FEDORAK, RN
    GERSHON, MD
    FIELD, M
    [J]. GASTROENTEROLOGY, 1989, 96 (01) : 37 - 44
  • [8] Inflammatory bowel disease: Etiology and pathogenesis
    Fiocchi, C
    [J]. GASTROENTEROLOGY, 1998, 115 (01) : 182 - 205
  • [9] Guberski DL, 1993, ILAR NEWS, V35, P29
  • [10] HARDIN JA, 1999, DIABETES RES, V34, P125